Ranbaxy to pay $500 million in DOJ settlement
India-based Ranbaxy Laboratories Ltd. has agreed to pay a total of $500 million in what the U.S. Department of Justice (DOJ) called the largest drug safety settlement to date with a generic drug manufacturer. The DOJ said Monday that Ranbaxy USA Inc., the company’s U.S.